 Robert Mcduffie
Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications, Infectious | 13 | 2004 | 407 | 0.760 |
Why?
| | Escherichia coli Infections | 9 | 2002 | 116 | 0.680 |
Why?
| | Fetal Diseases | 4 | 2002 | 180 | 0.430 |
Why?
| | Streptococcus agalactiae | 5 | 1999 | 91 | 0.380 |
Why?
| | Streptococcal Infections | 5 | 1999 | 152 | 0.360 |
Why?
| | Amniotic Fluid | 7 | 2002 | 79 | 0.350 |
Why?
| | Sulbactam | 5 | 2002 | 6 | 0.320 |
Why?
| | Ampicillin | 5 | 2002 | 14 | 0.320 |
Why?
| | Pregnancy | 33 | 2014 | 7039 | 0.320 |
Why?
| | Prenatal Care | 4 | 2004 | 301 | 0.300 |
Why?
| | Rabbits | 14 | 2004 | 754 | 0.290 |
Why?
| | Pregnancy Outcome | 5 | 2014 | 453 | 0.280 |
Why?
| | Uterine Diseases | 3 | 2002 | 17 | 0.280 |
Why?
| | Postpartum Hemorrhage | 1 | 2007 | 26 | 0.260 |
Why?
| | Balloon Occlusion | 1 | 2007 | 36 | 0.260 |
Why?
| | Catheterization | 1 | 2007 | 182 | 0.250 |
Why?
| | Office Visits | 2 | 1997 | 95 | 0.250 |
Why?
| | Twins | 2 | 2024 | 225 | 0.240 |
Why?
| | Diabetes, Gestational | 4 | 2012 | 318 | 0.230 |
Why?
| | alpha-Fetoproteins | 2 | 1996 | 40 | 0.230 |
Why?
| | Diseases in Twins | 1 | 2024 | 159 | 0.210 |
Why?
| | Bacteremia | 3 | 1999 | 216 | 0.200 |
Why?
| | Gardnerella vaginalis | 1 | 2002 | 3 | 0.200 |
Why?
| | Retinopathy of Prematurity | 1 | 2024 | 161 | 0.190 |
Why?
| | Birth Weight | 1 | 2024 | 511 | 0.180 |
Why?
| | Sialoglycoproteins | 2 | 2001 | 160 | 0.180 |
Why?
| | Bacterial Infections | 1 | 2002 | 245 | 0.160 |
Why?
| | Receptors, Interleukin-1 | 1 | 2001 | 215 | 0.160 |
Why?
| | Weight Gain | 2 | 2014 | 537 | 0.160 |
Why?
| | Pregnancy, Multiple | 1 | 1999 | 18 | 0.150 |
Why?
| | Meconium | 1 | 1999 | 6 | 0.150 |
Why?
| | Breast Diseases | 1 | 1999 | 22 | 0.150 |
Why?
| | Hepatitis A | 1 | 1999 | 26 | 0.150 |
Why?
| | Escherichia coli | 3 | 2002 | 836 | 0.150 |
Why?
| | Pregnancy Complications | 2 | 2014 | 577 | 0.150 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 1999 | 57 | 0.150 |
Why?
| | Puerperal Infection | 1 | 1998 | 5 | 0.150 |
Why?
| | Ofloxacin | 1 | 1998 | 17 | 0.140 |
Why?
| | Levofloxacin | 1 | 1998 | 20 | 0.140 |
Why?
| | Peritonitis | 1 | 1999 | 87 | 0.140 |
Why?
| | Uterus | 6 | 2007 | 221 | 0.140 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 123 | 0.140 |
Why?
| | Adiposity | 3 | 2013 | 519 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2002 | 1241 | 0.140 |
Why?
| | Breast Feeding | 2 | 2012 | 442 | 0.130 |
Why?
| | Female | 36 | 2024 | 75729 | 0.130 |
Why?
| | Trisomy | 2 | 1996 | 78 | 0.130 |
Why?
| | Fetal Death | 3 | 2002 | 59 | 0.130 |
Why?
| | Genital Diseases, Female | 1 | 1996 | 31 | 0.120 |
Why?
| | Health Services | 1 | 1997 | 116 | 0.120 |
Why?
| | Estriol | 1 | 1996 | 6 | 0.120 |
Why?
| | Chorionic Gonadotropin | 1 | 1996 | 78 | 0.120 |
Why?
| | Anti-Infective Agents | 1 | 1998 | 240 | 0.120 |
Why?
| | Infant, Newborn | 11 | 2024 | 6262 | 0.120 |
Why?
| | Ultrasonography, Prenatal | 2 | 1996 | 291 | 0.120 |
Why?
| | Pregnancy Trimester, Second | 2 | 1994 | 80 | 0.110 |
Why?
| | Aztreonam | 1 | 1995 | 11 | 0.110 |
Why?
| | Amnion | 1 | 1995 | 28 | 0.110 |
Why?
| | Obesity | 3 | 2014 | 3001 | 0.110 |
Why?
| | Drug Therapy, Combination | 5 | 2002 | 1042 | 0.110 |
Why?
| | Hemoperitoneum | 1 | 1994 | 12 | 0.110 |
Why?
| | Gentamicins | 1 | 1995 | 51 | 0.110 |
Why?
| | Prenatal Diagnosis | 1 | 1996 | 190 | 0.110 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 1994 | 39 | 0.110 |
Why?
| | Placenta Accreta | 1 | 1994 | 29 | 0.100 |
Why?
| | Ampicillin Resistance | 1 | 1993 | 1 | 0.100 |
Why?
| | Subcutaneous Fat | 1 | 2014 | 81 | 0.100 |
Why?
| | Klebsiella Infections | 1 | 1993 | 26 | 0.100 |
Why?
| | Klebsiella pneumoniae | 1 | 1993 | 46 | 0.100 |
Why?
| | Amoxicillin | 1 | 1993 | 35 | 0.100 |
Why?
| | Abortion, Veterinary | 1 | 1992 | 2 | 0.100 |
Why?
| | Fetus | 4 | 2002 | 799 | 0.100 |
Why?
| | Adolescent Development | 1 | 2013 | 89 | 0.100 |
Why?
| | Hyperinsulinism | 1 | 2013 | 114 | 0.090 |
Why?
| | Abnormalities, Multiple | 1 | 1994 | 197 | 0.090 |
Why?
| | Thiazolidinediones | 1 | 2013 | 137 | 0.090 |
Why?
| | Child of Impaired Parents | 1 | 2012 | 41 | 0.090 |
Why?
| | Cervix Uteri | 1 | 1992 | 51 | 0.090 |
Why?
| | Adiponectin | 1 | 2013 | 243 | 0.090 |
Why?
| | Down-Regulation | 1 | 2013 | 639 | 0.090 |
Why?
| | Cesarean Section | 2 | 2007 | 213 | 0.080 |
Why?
| | Physical Examination | 1 | 1992 | 242 | 0.080 |
Why?
| | Islets of Langerhans | 1 | 1996 | 803 | 0.080 |
Why?
| | Pregnancy in Diabetics | 1 | 2012 | 124 | 0.080 |
Why?
| | Body Mass Index | 3 | 2014 | 2377 | 0.080 |
Why?
| | Down Syndrome | 1 | 1996 | 505 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 1999 | 1493 | 0.070 |
Why?
| | Interleukin-1 | 1 | 1992 | 973 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 496 | 0.070 |
Why?
| | Disease Models, Animal | 6 | 2004 | 4413 | 0.070 |
Why?
| | Animals | 14 | 2004 | 37642 | 0.070 |
Why?
| | Fetal Growth Retardation | 1 | 2013 | 582 | 0.070 |
Why?
| | Maternal Age | 2 | 2005 | 128 | 0.070 |
Why?
| | Humans | 25 | 2024 | 141267 | 0.070 |
Why?
| | Adult | 12 | 2014 | 39203 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2004 | 3788 | 0.060 |
Why?
| | Hysterectomy | 1 | 2007 | 137 | 0.060 |
Why?
| | Health Maintenance Organizations | 2 | 1996 | 105 | 0.060 |
Why?
| | Arteries | 1 | 2007 | 261 | 0.060 |
Why?
| | Mass Screening | 4 | 2005 | 1304 | 0.060 |
Why?
| | Insulin Resistance | 1 | 2013 | 1218 | 0.060 |
Why?
| | Embolization, Therapeutic | 1 | 2007 | 242 | 0.060 |
Why?
| | Bacteroidaceae Infections | 1 | 2004 | 9 | 0.050 |
Why?
| | Prevotella | 1 | 2004 | 25 | 0.050 |
Why?
| | Obstetric Labor, Premature | 1 | 2004 | 40 | 0.050 |
Why?
| | Gestational Age | 2 | 2024 | 952 | 0.050 |
Why?
| | Waist Circumference | 2 | 2014 | 133 | 0.050 |
Why?
| | Time Factors | 5 | 2013 | 6971 | 0.050 |
Why?
| | Delivery, Obstetric | 1 | 2004 | 162 | 0.050 |
Why?
| | Random Allocation | 2 | 2001 | 366 | 0.050 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2001 | 255 | 0.050 |
Why?
| | Osmolar Concentration | 1 | 2002 | 167 | 0.050 |
Why?
| | Cohort Studies | 5 | 2013 | 5802 | 0.040 |
Why?
| | Risk Factors | 5 | 2024 | 10482 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2013 | 2089 | 0.040 |
Why?
| | Risk | 2 | 2013 | 904 | 0.040 |
Why?
| | Colorado | 5 | 2013 | 4599 | 0.040 |
Why?
| | Dinoprostone | 1 | 2001 | 189 | 0.040 |
Why?
| | Adolescent | 5 | 2013 | 22064 | 0.040 |
Why?
| | Body Temperature | 1 | 2001 | 224 | 0.040 |
Why?
| | Tetanus Toxoid | 1 | 1999 | 37 | 0.040 |
Why?
| | Chronic Disease | 2 | 2002 | 1812 | 0.040 |
Why?
| | Bacterial Vaccines | 1 | 1999 | 64 | 0.040 |
Why?
| | Polysaccharides, Bacterial | 1 | 1999 | 70 | 0.040 |
Why?
| | Ascites | 1 | 1999 | 47 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2013 | 2524 | 0.040 |
Why?
| | Autoimmunity | 1 | 2004 | 906 | 0.040 |
Why?
| | Fatal Outcome | 1 | 1999 | 308 | 0.040 |
Why?
| | Retrospective Studies | 4 | 2024 | 16373 | 0.040 |
Why?
| | Animals, Newborn | 2 | 1999 | 867 | 0.030 |
Why?
| | Drug Administration Schedule | 2 | 2002 | 773 | 0.030 |
Why?
| | Fetal Movement | 1 | 1997 | 7 | 0.030 |
Why?
| | Fetal Monitoring | 1 | 1997 | 20 | 0.030 |
Why?
| | Male | 9 | 2024 | 70063 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 2013 | 3343 | 0.030 |
Why?
| | Genotype | 2 | 2004 | 1865 | 0.030 |
Why?
| | Oropharynx | 1 | 1996 | 44 | 0.030 |
Why?
| | Amniocentesis | 1 | 1996 | 20 | 0.030 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 1996 | 8 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 1996 | 123 | 0.030 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 1996 | 44 | 0.030 |
Why?
| | Karyotyping | 1 | 1996 | 104 | 0.030 |
Why?
| | Registries | 1 | 2024 | 2177 | 0.030 |
Why?
| | Acoustic Stimulation | 1 | 1997 | 324 | 0.030 |
Why?
| | Glutamate Decarboxylase | 1 | 1996 | 166 | 0.030 |
Why?
| | Administration, Oral | 1 | 1998 | 824 | 0.030 |
Why?
| | Insulin Antibodies | 1 | 1996 | 103 | 0.030 |
Why?
| | HLA-DQ Antigens | 1 | 1996 | 178 | 0.030 |
Why?
| | Genetic Counseling | 1 | 1996 | 81 | 0.030 |
Why?
| | Child | 5 | 2014 | 22342 | 0.030 |
Why?
| | Chromosome Aberrations | 1 | 1996 | 161 | 0.030 |
Why?
| | HLA-DR Antigens | 1 | 1996 | 227 | 0.030 |
Why?
| | Infant, Low Birth Weight | 1 | 1996 | 145 | 0.030 |
Why?
| | HLA Antigens | 1 | 1996 | 234 | 0.030 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1996 | 169 | 0.030 |
Why?
| | Ultrasonography | 1 | 1999 | 764 | 0.030 |
Why?
| | Endometrium | 1 | 1995 | 62 | 0.030 |
Why?
| | Dandy-Walker Syndrome | 1 | 1994 | 7 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2011 | 656 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2014 | 196 | 0.030 |
Why?
| | Pre-Eclampsia | 1 | 1996 | 200 | 0.030 |
Why?
| | Indomethacin | 1 | 1993 | 87 | 0.030 |
Why?
| | Antithrombin III Deficiency | 1 | 1993 | 8 | 0.030 |
Why?
| | Subclavian Vein | 1 | 1993 | 15 | 0.030 |
Why?
| | Abdominal Fat | 1 | 2013 | 41 | 0.030 |
Why?
| | Pregnancy Complications, Hematologic | 1 | 1993 | 25 | 0.020 |
Why?
| | Alleles | 1 | 1996 | 884 | 0.020 |
Why?
| | Chorioamnionitis | 1 | 1993 | 45 | 0.020 |
Why?
| | Sulfonylurea Compounds | 1 | 2013 | 50 | 0.020 |
Why?
| | Fetal Blood | 3 | 2004 | 336 | 0.020 |
Why?
| | Cytokines | 1 | 2000 | 2093 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 1996 | 465 | 0.020 |
Why?
| | Warfarin | 1 | 1993 | 168 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 1996 | 691 | 0.020 |
Why?
| | Pregnancy Trimester, Third | 1 | 1992 | 113 | 0.020 |
Why?
| | Infant, Premature | 1 | 1996 | 598 | 0.020 |
Why?
| | Injections, Intramuscular | 1 | 1991 | 135 | 0.020 |
Why?
| | Brain | 1 | 2002 | 2855 | 0.020 |
Why?
| | Prospective Studies | 3 | 2014 | 7787 | 0.020 |
Why?
| | Progesterone | 1 | 1991 | 258 | 0.020 |
Why?
| | Infant | 2 | 2012 | 9801 | 0.020 |
Why?
| | Obstetrics | 1 | 1992 | 176 | 0.020 |
Why?
| | Metformin | 1 | 2013 | 330 | 0.020 |
Why?
| | Thrombosis | 1 | 1993 | 399 | 0.020 |
Why?
| | Anti-Bacterial Agents | 2 | 1996 | 1865 | 0.020 |
Why?
| | Autoantibodies | 1 | 1996 | 1474 | 0.020 |
Why?
| | Biomarkers | 2 | 1996 | 4179 | 0.020 |
Why?
| | Algorithms | 1 | 1994 | 1764 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2923 | 0.010 |
Why?
| | Birth Order | 1 | 2004 | 13 | 0.010 |
Why?
| | Placenta | 2 | 2000 | 764 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2004 | 328 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 1015 | 0.010 |
Why?
| | Treatment Failure | 1 | 2002 | 354 | 0.010 |
Why?
| | Opsonin Proteins | 1 | 1999 | 24 | 0.010 |
Why?
| | Peritoneum | 1 | 1999 | 47 | 0.010 |
Why?
| | Vaccines, Conjugate | 1 | 1999 | 63 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1999 | 191 | 0.010 |
Why?
| | Antibodies, Bacterial | 1 | 1999 | 145 | 0.010 |
Why?
| | Acute Disease | 1 | 2000 | 1012 | 0.010 |
Why?
| | Palpation | 1 | 1997 | 17 | 0.010 |
Why?
| | Child, Preschool | 1 | 2012 | 11473 | 0.010 |
Why?
| | NF-kappa B | 1 | 2000 | 690 | 0.010 |
Why?
| | Quality Control | 1 | 1996 | 162 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 508 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 1999 | 899 | 0.010 |
Why?
| | Uterine Cervical Diseases | 1 | 1993 | 6 | 0.010 |
Why?
| | Premedication | 1 | 1993 | 42 | 0.010 |
Why?
| | Contraindications | 1 | 1993 | 86 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1996 | 1052 | 0.010 |
Why?
| | Patient Compliance | 1 | 1996 | 608 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2004 | 5937 | 0.010 |
Why?
| | Inflammation | 1 | 2002 | 2895 | 0.010 |
Why?
| | Feasibility Studies | 1 | 1994 | 1025 | 0.010 |
Why?
| | Incidence | 1 | 1996 | 2800 | 0.000 |
Why?
| | Lung | 1 | 2000 | 4129 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1996 | 5213 | 0.000 |
Why?
| | Treatment Outcome | 1 | 1993 | 11194 | 0.000 |
Why?
|
|
Mcduffie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|